FDA Inspection 1113302 — Novetide Ltd.
The FDA completed an inspection of Novetide Ltd. on Nov 14, 2019 in Netanya. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 14, 2019
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Netanya (Israel)